BSECompany Update6d ago · 13 Aug 2026, 05:28 pm

Report of Monitoring Agency for the Quarter ended on June 30, 2026.

Shivam Autotech Ltd · 532776

✦ AI SummaryFundraise

Shivam Autotech Ltd has received a monitoring agency report from CARE Ratings Ltd for the quarter ended June 30, 2026, related to the preferential issue of optionally convertible debentures worth Rs. 120 crores.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shivam Autotech Ltd - 532776 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Attachments (1)

📄

67278c6d-c711-46c8-95c2-d3e6943bbc58.pdf

pdf

Download →
View document text
Date: August 13, 2026 The National Stock Exchange of India Limited The BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroje Jeejeebhoy Towers Bandra East, Dalal Street Fort Mumbai – 400 051 Mumbai – 400 001 (Scrip Code – SHIVAMAUTO) (Scrip Code – 532776) Sub: Monitoring Agency Report for the quarter ended June 30, 2026 Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41(2) and 173A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed Monitoring Agency Report for the quarter ended June 30, 2026, issued by CARE Ratings Limited. You are requested to take the information on record and disseminate. Thanking you. Yours truly, For Shivam Autotech Limited Mehvish Company Secretary and Compliance Officer SHIVAM AUTOTECH LIMITED www. shivamautotech.com CIN: L34300HR2005PLC081531 Registered Office: 10, 1st Floor, Emaar Digital Greens, Tower A, Sector 61, Tel: 0124-4698700 Golf Course Extension Road, Gurugram, Haryana-122102 Fax: 0124-4698798 No. CARE/NRO/GEN/2026-27/1090 The Board of Directors Shivam Autotech Limited Towe, A, 10 1st floor, Emaar Digital Greens, Sector-61 Gurgaon Haryana-122001 August 10, 2026 Dear Sir, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the preferential issue of optionally convertible debentures of Shivam Autotech Limited (“the Company”) We write in our capacity of Monitoring Agency for the preferential issue of optionally convertible debentures for the amount aggregating to Rs. 120 crores of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated February 02, 2026. Request you to kindly take the same on records. Thanking you, Yours faithfully, Akhil Kumar Associate Director Akhil.kumar@careedge.in CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Shivam Autotech Ltd For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: No (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Akhil Kumar Designation of Authorized person/Signing Authority: Associate director CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : Shivam Autotech Ltd Name of the promoter : Dayanand Munjal Investments Pvt. Ltd. Industry/sector to which it belongs : Automobile & Auto components 2) Issue Details Issue Period : February 10, 2026 to February 11, 2026 (Tranche -1: Rs. 75 crore) and February 11, 2026 to February 12, 2026 (Tranche – 2: Rs. 45 crore) Type of issue (public/rights) : Preferential issue Type of specified securities : Optionally convertible debentures IPO Grading, if any : Not applicable Issue size (in crore) : Rs. 120 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications considered by Comments of the Comments of the Particulars Reply Monitoring Agency for Monitoring Agency Board of Directors preparation of report The issue proceeds have been utilized in The Company had requested the accordance with the objects given as per release of the funds lying in the offer documents and unutilised amount escrow account during July Management Certificate, CA has been maintained in the OCD escrow 2026. Upon receipt of the Whether all utilization is as per the disclosures in Certificate, PAS-4 forms for account. requisite approvals, the funds the Offer Document? Tranche-1 & 2, OCD However, there is delay in utilisation of were released and subsequently Subscription Agreement issue proceeds towards each object as deployed towards the stated follows: object in July 2026. Accordingly, • The company was unable to the amount was utilized deploy ₹5 crore (Part of immediately upon its release. CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Source of information / certifications considered by Comments of the Comments of the Particulars Reply Monitoring Agency for Monitoring Agency Board of Directors preparation of report Tranche-2) towards long-term working capital within the The Company completed the stipulated fifteen days from repayment of the NCDs within receipt of funds and applicable the stipulated timeline as approvals, whichever is later. mentioned in the Offer (Note-1) Document. As of March 31, • Although ₹115 crore (Tranche 1 2026, an amount of ₹9.85 crore & 2) was earmarked for was receivable by the Company repayment of NCDs issued to towards reimbursement of its ALPHA Alternatives Structured own funds that had been utilized Credit Opportunities (AASCO) for the repayment of the NCDs. within seven days of receipt of During the quarte [Showing first 8,000 characters — download PDF for full document]